CN Stock MarketDetailed Quotes

Henan Taloph Pharmaceutical Stock (600222)

Watchlist
  • 7.78
  • +0.15+1.97%
Not Open May 14 15:00 CST
4.46BMarket Cap73.40P/E (TTM)

Henan Taloph Pharmaceutical Stock (600222) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
8.34%350.23M
-9.46%1.76B
-11.47%1.19B
-17.77%762.43M
-35.23%323.27M
-6.21%1.94B
-7.08%1.34B
-6.71%927.25M
-10.92%499.11M
5.57%2.07B
Operating revenue
8.34%350.23M
-9.46%1.76B
-11.47%1.19B
-17.77%762.43M
-35.23%323.27M
-6.21%1.94B
-7.08%1.34B
-6.71%927.25M
-10.92%499.11M
5.57%2.07B
Other operating revenue
----
-45.26%2.85M
----
-27.70%2.12M
----
4.95%5.2M
----
121.85%2.93M
----
-67.68%4.95M
Total operating cost
7.71%347.5M
-13.52%1.66B
-13.30%1.17B
-18.07%749.19M
-34.05%322.64M
-5.60%1.92B
-8.68%1.35B
-11.74%914.38M
-12.33%489.24M
2.07%2.04B
Operating cost
9.22%258.41M
-12.39%1.27B
-8.82%898.6M
-13.81%574.17M
-34.75%236.6M
-4.03%1.44B
-8.57%985.57M
-11.20%666.19M
-10.87%362.61M
1.11%1.51B
Operating tax surcharges
28.56%2.02M
5.56%11.74M
-3.07%7.18M
-4.90%5.25M
-41.28%1.57M
12.08%11.12M
17.44%7.41M
20.75%5.52M
9.69%2.68M
17.81%9.93M
Operating expense
-7.20%28.51M
-23.24%131.21M
-31.18%88.35M
-32.81%57.99M
-37.26%30.72M
-13.61%170.93M
-11.00%128.37M
-13.50%86.31M
-37.74%48.97M
8.10%197.86M
Administration expense
3.44%26.86M
-6.96%127.15M
-12.42%90.57M
-12.96%59.05M
-28.50%25.97M
-3.52%136.65M
-0.60%103.41M
-10.44%67.85M
9.26%36.32M
5.32%141.64M
Financial expense
1.62%14.84M
1.49%58.45M
0.00%44.16M
-5.41%26.82M
1.51%14.61M
7.59%57.6M
11.76%44.16M
9.28%28.36M
13.47%14.39M
-15.76%53.53M
-Interest expense (Financial expense)
-2.61%13.98M
-4.70%53.68M
1.60%41.36M
-9.03%24.75M
4.72%14.35M
8.75%56.33M
6.26%40.71M
10.35%27.21M
13.06%13.71M
-12.08%51.8M
-Interest Income (Financial expense)
-120.81%-275.03K
55.04%-1.64M
49.60%-383.87K
55.78%-370K
20.42%-124.56K
-67.77%-3.64M
55.27%-761.68K
26.27%-836.74K
4.86%-156.52K
2.15%-2.17M
Research and development
27.99%16.86M
-32.82%67.78M
-50.59%38.1M
-56.93%25.91M
-45.75%13.17M
-21.00%100.89M
-24.41%77.12M
-24.57%60.15M
0.38%24.28M
9.61%127.71M
Credit Impairment Loss
-318.83%-1.91M
-727.47%-22.27M
-33.49%7.52M
-168.63%-4.04M
-87.58%873.98K
913.34%3.55M
8.98%11.31M
340.20%5.89M
206.47%7.04M
97.96%-436.45K
Asset Impairment Loss
-431.23%-2.06M
23.32%-5.62M
-103.93%-178.22K
808.45%9.81M
90.43%-387.28K
-197.43%-7.32M
194.74%4.53M
68.64%-1.38M
-757.04%-4.05M
85.78%-2.46M
Other net revenue
-111.51%-230.36K
-213.27%-18.18M
-51.37%14.61M
25.43%11.26M
-71.53%2M
58.69%16.05M
187.94%30.04M
246.83%8.97M
1,220.72%7.03M
127.45%10.12M
Fair value change income
2,359.95%3.52M
-82.37%1.4M
-76.14%1.46M
187.79%1.45M
158.45%142.97K
1,586.33%7.94M
932.39%6.12M
161.56%504.41K
74.73%-244.62K
93.47%-534.04K
Invest income
-4,315.21%-1.79M
-105.66%-154.77K
-125.23%-265.27K
-149.58%-596.65K
-101.56%-40.57K
146.47%2.74M
126.39%1.05M
148.39%1.2M
249.20%2.59M
-102.27%-5.89M
-Including: Investment income associates
-4,315.21%-1.79M
-2,703.29%-3.44M
4.26%-928.53K
-85.70%-1.26M
-102.29%-40.57K
101.59%132.1K
77.31%-969.89K
72.88%-678.46K
200.82%1.77M
-37.20%-8.33M
Asset deal income
----
-118.45%-23.97K
--0
--0
----
-78.89%129.92K
-74.89%111.63K
-80.38%113.29K
-8.38%113.55K
1,008.91%615.49K
Other revenue
42.58%2.01M
-5.96%8.49M
-12.25%6.07M
74.66%4.63M
-10.47%1.41M
-52.06%9.02M
-11.16%6.92M
-23.83%2.65M
22.21%1.58M
44.83%18.82M
Operating profit
-5.27%2.5M
117.55%77.71M
39.98%34.54M
12.15%24.5M
-84.40%2.64M
-19.13%35.72M
218.96%24.67M
145.26%21.84M
500.04%16.9M
162.40%44.17M
Add:Non operating Income
-98.15%689.04
1.91%185.93K
330.59%40.2K
42.46%40.2K
--37.18K
2,029.99%182.44K
9.02%9.34K
5,249.90%28.22K
----
-93.52%8.57K
Less:Non operating expense
-99.82%50
-52.99%388.99K
6.07%276.43K
61.17%178.69K
1,253.00%27.06K
-31.76%827.51K
0.88%260.6K
-15.19%110.88K
-44.37%2K
-90.06%1.21M
Total profit
-5.61%2.5M
120.98%77.51M
40.45%34.3M
11.94%24.36M
-84.34%2.65M
-18.36%35.07M
216.35%24.42M
144.97%21.76M
500.73%16.9M
151.86%42.96M
Less:Income tax cost
1,146.84%182.07K
163.18%11.64M
169.23%3.83M
141.16%1.76M
100.40%14.6K
-886.77%-18.42M
-276.11%-5.53M
23.09%-4.27M
-661.92%-3.63M
73.66%-1.87M
Net profit
-12.01%2.32M
23.13%65.87M
1.76%30.47M
-13.17%22.6M
-87.18%2.63M
19.33%53.5M
253.41%29.95M
160.76%26.03M
524.06%20.52M
159.17%44.83M
Net profit from continuing operation
-12.01%2.32M
23.13%65.87M
1.76%30.47M
-13.17%22.6M
-87.18%2.63M
19.33%53.5M
253.41%29.95M
160.76%26.03M
524.06%20.52M
159.17%44.83M
Less:Minority Profit
-125.98%-285.96K
97.68%5.87M
389.62%5.15M
653.25%3.26M
249.29%1.1M
133.40%2.97M
140.54%1.05M
86.95%-588.35K
-87.02%-737.21K
135.76%1.27M
Net profit of parent company owners
69.95%2.6M
18.74%60M
-12.36%25.33M
-27.32%19.35M
-92.80%1.53M
16.00%50.53M
270.72%28.9M
169.44%26.62M
477.28%21.26M
160.32%43.56M
Earning per share
Basic earning per share
67.86%0.0047
19.49%0.1085
-11.75%0.0458
-26.62%0.035
-92.65%0.0028
17.31%0.0908
273.00%0.0519
170.46%0.0477
486.15%0.0381
160.28%0.0774
Diluted earning per share
67.86%0.0047
19.49%0.1085
-11.75%0.0458
-26.62%0.035
-92.65%0.0028
17.31%0.0908
273.00%0.0519
170.46%0.0477
486.15%0.0381
160.28%0.0774
Other composite income
89.26%-708.43K
20.93%-13.82M
-250.01%-20.23M
69.21%-6.72M
23.99%-6.6M
-365.30%-17.48M
90.45%-5.78M
69.34%-21.83M
70.70%-8.68M
104.98%6.59M
Other composite income of parent company owners
89.26%-708.43K
20.93%-13.82M
-250.01%-20.23M
69.21%-6.72M
23.99%-6.6M
-365.30%-17.48M
90.45%-5.78M
69.34%-21.83M
70.70%-8.68M
105.97%6.59M
Total composite income
140.52%1.61M
44.50%52.05M
-57.61%10.25M
278.51%15.88M
-133.48%-3.97M
-29.95%36.02M
130.19%24.17M
103.68%4.2M
144.98%11.84M
124.72%51.42M
Total composite income of parent company owners
137.36%1.89M
39.72%46.18M
-77.95%5.1M
163.91%12.62M
-140.27%-5.07M
-34.09%33.05M
129.85%23.12M
104.37%4.78M
148.50%12.58M
127.47%50.14M
Total composite income of minority owners
-125.98%-285.96K
97.68%5.87M
389.62%5.15M
653.25%3.26M
249.29%1.1M
133.40%2.97M
140.54%1.05M
86.95%-588.35K
-87.02%-737.21K
105.01%1.27M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Beijing Xinghua Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 8.34%350.23M-9.46%1.76B-11.47%1.19B-17.77%762.43M-35.23%323.27M-6.21%1.94B-7.08%1.34B-6.71%927.25M-10.92%499.11M5.57%2.07B
Operating revenue 8.34%350.23M-9.46%1.76B-11.47%1.19B-17.77%762.43M-35.23%323.27M-6.21%1.94B-7.08%1.34B-6.71%927.25M-10.92%499.11M5.57%2.07B
Other operating revenue -----45.26%2.85M-----27.70%2.12M----4.95%5.2M----121.85%2.93M-----67.68%4.95M
Total operating cost 7.71%347.5M-13.52%1.66B-13.30%1.17B-18.07%749.19M-34.05%322.64M-5.60%1.92B-8.68%1.35B-11.74%914.38M-12.33%489.24M2.07%2.04B
Operating cost 9.22%258.41M-12.39%1.27B-8.82%898.6M-13.81%574.17M-34.75%236.6M-4.03%1.44B-8.57%985.57M-11.20%666.19M-10.87%362.61M1.11%1.51B
Operating tax surcharges 28.56%2.02M5.56%11.74M-3.07%7.18M-4.90%5.25M-41.28%1.57M12.08%11.12M17.44%7.41M20.75%5.52M9.69%2.68M17.81%9.93M
Operating expense -7.20%28.51M-23.24%131.21M-31.18%88.35M-32.81%57.99M-37.26%30.72M-13.61%170.93M-11.00%128.37M-13.50%86.31M-37.74%48.97M8.10%197.86M
Administration expense 3.44%26.86M-6.96%127.15M-12.42%90.57M-12.96%59.05M-28.50%25.97M-3.52%136.65M-0.60%103.41M-10.44%67.85M9.26%36.32M5.32%141.64M
Financial expense 1.62%14.84M1.49%58.45M0.00%44.16M-5.41%26.82M1.51%14.61M7.59%57.6M11.76%44.16M9.28%28.36M13.47%14.39M-15.76%53.53M
-Interest expense (Financial expense) -2.61%13.98M-4.70%53.68M1.60%41.36M-9.03%24.75M4.72%14.35M8.75%56.33M6.26%40.71M10.35%27.21M13.06%13.71M-12.08%51.8M
-Interest Income (Financial expense) -120.81%-275.03K55.04%-1.64M49.60%-383.87K55.78%-370K20.42%-124.56K-67.77%-3.64M55.27%-761.68K26.27%-836.74K4.86%-156.52K2.15%-2.17M
Research and development 27.99%16.86M-32.82%67.78M-50.59%38.1M-56.93%25.91M-45.75%13.17M-21.00%100.89M-24.41%77.12M-24.57%60.15M0.38%24.28M9.61%127.71M
Credit Impairment Loss -318.83%-1.91M-727.47%-22.27M-33.49%7.52M-168.63%-4.04M-87.58%873.98K913.34%3.55M8.98%11.31M340.20%5.89M206.47%7.04M97.96%-436.45K
Asset Impairment Loss -431.23%-2.06M23.32%-5.62M-103.93%-178.22K808.45%9.81M90.43%-387.28K-197.43%-7.32M194.74%4.53M68.64%-1.38M-757.04%-4.05M85.78%-2.46M
Other net revenue -111.51%-230.36K-213.27%-18.18M-51.37%14.61M25.43%11.26M-71.53%2M58.69%16.05M187.94%30.04M246.83%8.97M1,220.72%7.03M127.45%10.12M
Fair value change income 2,359.95%3.52M-82.37%1.4M-76.14%1.46M187.79%1.45M158.45%142.97K1,586.33%7.94M932.39%6.12M161.56%504.41K74.73%-244.62K93.47%-534.04K
Invest income -4,315.21%-1.79M-105.66%-154.77K-125.23%-265.27K-149.58%-596.65K-101.56%-40.57K146.47%2.74M126.39%1.05M148.39%1.2M249.20%2.59M-102.27%-5.89M
-Including: Investment income associates -4,315.21%-1.79M-2,703.29%-3.44M4.26%-928.53K-85.70%-1.26M-102.29%-40.57K101.59%132.1K77.31%-969.89K72.88%-678.46K200.82%1.77M-37.20%-8.33M
Asset deal income -----118.45%-23.97K--0--0-----78.89%129.92K-74.89%111.63K-80.38%113.29K-8.38%113.55K1,008.91%615.49K
Other revenue 42.58%2.01M-5.96%8.49M-12.25%6.07M74.66%4.63M-10.47%1.41M-52.06%9.02M-11.16%6.92M-23.83%2.65M22.21%1.58M44.83%18.82M
Operating profit -5.27%2.5M117.55%77.71M39.98%34.54M12.15%24.5M-84.40%2.64M-19.13%35.72M218.96%24.67M145.26%21.84M500.04%16.9M162.40%44.17M
Add:Non operating Income -98.15%689.041.91%185.93K330.59%40.2K42.46%40.2K--37.18K2,029.99%182.44K9.02%9.34K5,249.90%28.22K-----93.52%8.57K
Less:Non operating expense -99.82%50-52.99%388.99K6.07%276.43K61.17%178.69K1,253.00%27.06K-31.76%827.51K0.88%260.6K-15.19%110.88K-44.37%2K-90.06%1.21M
Total profit -5.61%2.5M120.98%77.51M40.45%34.3M11.94%24.36M-84.34%2.65M-18.36%35.07M216.35%24.42M144.97%21.76M500.73%16.9M151.86%42.96M
Less:Income tax cost 1,146.84%182.07K163.18%11.64M169.23%3.83M141.16%1.76M100.40%14.6K-886.77%-18.42M-276.11%-5.53M23.09%-4.27M-661.92%-3.63M73.66%-1.87M
Net profit -12.01%2.32M23.13%65.87M1.76%30.47M-13.17%22.6M-87.18%2.63M19.33%53.5M253.41%29.95M160.76%26.03M524.06%20.52M159.17%44.83M
Net profit from continuing operation -12.01%2.32M23.13%65.87M1.76%30.47M-13.17%22.6M-87.18%2.63M19.33%53.5M253.41%29.95M160.76%26.03M524.06%20.52M159.17%44.83M
Less:Minority Profit -125.98%-285.96K97.68%5.87M389.62%5.15M653.25%3.26M249.29%1.1M133.40%2.97M140.54%1.05M86.95%-588.35K-87.02%-737.21K135.76%1.27M
Net profit of parent company owners 69.95%2.6M18.74%60M-12.36%25.33M-27.32%19.35M-92.80%1.53M16.00%50.53M270.72%28.9M169.44%26.62M477.28%21.26M160.32%43.56M
Earning per share
Basic earning per share 67.86%0.004719.49%0.1085-11.75%0.0458-26.62%0.035-92.65%0.002817.31%0.0908273.00%0.0519170.46%0.0477486.15%0.0381160.28%0.0774
Diluted earning per share 67.86%0.004719.49%0.1085-11.75%0.0458-26.62%0.035-92.65%0.002817.31%0.0908273.00%0.0519170.46%0.0477486.15%0.0381160.28%0.0774
Other composite income 89.26%-708.43K20.93%-13.82M-250.01%-20.23M69.21%-6.72M23.99%-6.6M-365.30%-17.48M90.45%-5.78M69.34%-21.83M70.70%-8.68M104.98%6.59M
Other composite income of parent company owners 89.26%-708.43K20.93%-13.82M-250.01%-20.23M69.21%-6.72M23.99%-6.6M-365.30%-17.48M90.45%-5.78M69.34%-21.83M70.70%-8.68M105.97%6.59M
Total composite income 140.52%1.61M44.50%52.05M-57.61%10.25M278.51%15.88M-133.48%-3.97M-29.95%36.02M130.19%24.17M103.68%4.2M144.98%11.84M124.72%51.42M
Total composite income of parent company owners 137.36%1.89M39.72%46.18M-77.95%5.1M163.91%12.62M-140.27%-5.07M-34.09%33.05M129.85%23.12M104.37%4.78M148.50%12.58M127.47%50.14M
Total composite income of minority owners -125.98%-285.96K97.68%5.87M389.62%5.15M653.25%3.26M249.29%1.1M133.40%2.97M140.54%1.05M86.95%-588.35K-87.02%-737.21K105.01%1.27M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)------Beijing Xinghua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More